Clinical Trial Update: Phase 2 Study With SNF472 in Calciphylaxis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SNF472 in calciphylaxis (calcific uremic arteriolopathy) completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcific Uremic Arteriolopathy
• Calciphylaxis

Drugs mentioned

• SNF472 (SNF472)

Snippet

Sponsor: Sanifit Therapeutics S. A. | Conditions: Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 2 | Status: COMPLETED | Results posted: 2019-08-28